The State-of-the-Art Mycology Laboratory: Visions of the Future
The State-of-the-Art Mycology Laboratory: Visions of the Future
复制标题
DOI:
10.1007/s12281-014-0212-z
复制
发表时间:
2015-03-01
影响因子:
1.4
通讯作者:
Guinea, Jesus
中科院分区:
文献类型:
--
作者:
Arendrup, Maiken Cavling;Posteraro, Brunella;Guinea, Jesus
Invasive infections have emerged over the past decades as important causes for morbidity and mortality. Favorable outcome is associated with early and appropriate antifungal treatment. Therefore, rapid and correct diagnosis is of utmost importance. The clinical mycology field has evolved over the past decade. Reference methods for susceptibility testing and associated clinical breakpoints for Candida and Aspergillus have been developed, and several commercial susceptibility tests have been marketed. New diagnostic tests have become available including ELISA and lateral flow devices for the detection of Aspergillus, Candida, and Cryptococcus antigens; beta-D-glucan detection test; diagnostic PCRs; and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) techniques for identification and perhaps in the future also for susceptibility screening (testing). Finally, molecular sequencing and genotyping methods have tance detection. Some of these tests are straightforward to implement in the routine laboratory for clinical microbiology, whereas others require mycological expertise. Here, we present an overview of the newer diagnostic options, review options for improving sensitivity of classical diagnostic techniques, and also comment on which levels of mycological expertise are required for the different diagnostic tests. The goal of this review is to summarize current diagnostic options and discuss benefits and pitfalls on how these are best implemented in order to obtain state-of-the-art mycology service.